Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 for Intestinal Permeability in Ulcerative Colitis
NCT01479660Phase 4Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Mar 2011
- Primary completion
- Oct 2014
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of VSL#3 in ulcerative colitis (UC), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Disease Activity Index at 12 weeks. Status: unknown.
02
Drugs
VSL#3
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01479660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479660.